Saniona AB (publ) (STO:SANION)
Sweden · Delayed Price · Currency is SEK 16.16
-2.46 (-13.21%)
At close: Mar 2, 2026
Saniona AB Revenue
In the year 2025, Saniona AB had annual revenue of 434.40M SEK with 29.80% growth. Saniona AB had revenue of 4.58M in the quarter ending December 31, 2025, a decrease of -98.54%.
Revenue
434.40M
Revenue Growth
+29.80%
P/S Ratio
5.13
Revenue / Employee
14.01M
Employees
31
Market Cap
2.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 434.40M | 99.73M | 29.80% |
| Dec 31, 2024 | 334.67M | 317.83M | 1,887.36% |
| Dec 31, 2023 | 16.84M | 1.56M | 10.19% |
| Dec 31, 2022 | 15.28M | 4.81M | 45.86% |
| Dec 31, 2021 | 10.48M | 2.28M | 27.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 316.70M |
| BioInvent International AB | 226.50M |
| Hansa Biopharma AB | 222.27M |
| Genovis AB (publ.) | 129.65M |
| Egetis Therapeutics AB | 62.40M |
| Medivir AB | 8.50M |
| Xspray Pharma AB | 6.43M |
| Vicore Pharma Holding AB | 3.82M |
Saniona AB News
- 3 months ago - Saniona AB (FRA:30S) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial ... - GuruFocus
- 3 months ago - Q3 2025 Saniona AB Earnings Call Transcript - GuruFocus